Adding screening for spinal muscular atrophy to the neonatal blood screening

Early recognition of spinal muscular atrophy (SMA) allows for the presymptomatic treatment of children with the most severe variety of the disease. This (partially) prevents irreversible damage to the nervous system. Therefore the Health Council of the Netherlands recommends to add SMA to the neonatal screening.